

Righton Biology, a specialized molecular diagnostics company with test kits for leukemia, lymphoma, and solid tumors, today announced that it had completed its Series A financing.

Yunniao Distribution, which operates an mobile enabled platform for dispatching trucks and meeting fulfillment and transportation demands, announced today that it had raised $100 million in Series C financing.


Xingshulin, a leading mobile app focused on providing data and management tools to physicians across the country, announced today that it had completed Series C financing.

Baofeng Magic Glasses, an affiliate of Baofeng Technology, an A-share listed company in China, and the largest supplier of VR glasses in China, announced today that it had raised RMB 230 million in Series B financing.

ET Healthcare, an advanced in-vitro diagnostic technology company, announced today that it had completed a new round of financing, led by Qiming Venture Partners and Masion Capital with participation from the compan's existing shareholders Legend Capital

Zhenrongbao, an mobile-based asset management platform, announced today that it had completed its Series B financing. Sequoia Capital China led this round.

In September 16th, UR Work established only for 5 months announces that it has closed the A round of financing with over two hundred million Yuan RMB.